α-Tocopheryl succinate alters cell cycle distribution sensitising human osteosarcoma cells to methotrexate-induced apoptosis

Renata Alleva, Maria Serena Benassi, Laura Pazzaglia, Marco Tomasetti, Nina Gellert, Battista Borghi, Jiri Neuzil, Piero Picci

Research output: Contribution to journalArticlepeer-review

Abstract

α-Tocopheryl succinate (α-TOS) exerts pleiotrophic responses in malignant cells leading to cell cycle arrest, differentiation and apoptosis. We tested the ability of α-TOS to induce apoptosis or cell cycle perturbation in three human osteosarcoma (OS) cell lines which differ in their pRB and p53 status. We found high levels of apoptosis in OS cells carrying wild-type p53 gene when exposed to α-TOS, while the mutant p53 cells were resistant. A S/G2 transition arrest was observed in two OS cell lines exposed to α-TOS, which sensitised them to methotrexate, an agent whose activity is cell cycle-dependent. We propose that α-TOS may be used as a drug or an adjuvant for treatment of osteosarcomas.

Original languageEnglish
Pages (from-to)226-235
Number of pages10
JournalCancer Letters
Volume232
Issue number2
DOIs
Publication statusPublished - Feb 8 2006

Keywords

  • α-Tocopheryl succinate
  • Apoptosis
  • Cell cycle
  • Methotrexate
  • Osteosarcoma cells

ASJC Scopus subject areas

  • Cancer Research
  • Molecular Biology
  • Oncology

Fingerprint

Dive into the research topics of 'α-Tocopheryl succinate alters cell cycle distribution sensitising human osteosarcoma cells to methotrexate-induced apoptosis'. Together they form a unique fingerprint.

Cite this